Clinical trial
Evaluation of Bioequivalence of Lamotrigine Tablets in Epileptic Patients
NCT01995825 is registered in ClinicalTrials.gov with University of Maryland, Baltimore as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Evaluation of Bioequivalence of Lamotrigine Tablets in Epileptic Patients
- Lead sponsor
- University of Maryland, Baltimore
- Phase
- Phase 4
- Overall status
- Completed
- Start date
- May 31, 2012
- Completion date
- October 31, 2013
- Enrollment
- 35 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.